{"id":858573,"date":"2023-09-14T13:20:02","date_gmt":"2023-09-14T13:19:08","guid":{"rendered":"https:\/\/omni48.com\/?p=858573"},"modified":"2023-09-24T13:23:23","modified_gmt":"2023-09-24T13:23:23","slug":"okyo-pharma-down-4-withdraws-public-offering","status":"publish","type":"post","link":"https:\/\/omni48.com\/stocks\/okyo-pharma-down-4-withdraws-public-offering","title":{"rendered":"OKYO Pharma down 4%, withdraws public offering"},"content":{"rendered":"<p>An ophthalmology-focused bio-pharmaceutical company OKYO Pharma (NASDAQ:OKYO) withdraws its proposed public&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An ophthalmology-focused bio-pharmaceutical company OKYO Pharma (NASDAQ:OKYO) withdraws its proposed public&#8230;<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[24],"tags":[],"class_list":["post-858573","post","type-post","status-publish","format-standard","hentry","category-stocks"],"acf":[],"_links":{"self":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/858573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/comments?post=858573"}],"version-history":[{"count":0,"href":"https:\/\/omni48.com\/api\/wp\/v2\/posts\/858573\/revisions"}],"wp:attachment":[{"href":"https:\/\/omni48.com\/api\/wp\/v2\/media?parent=858573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/categories?post=858573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/omni48.com\/api\/wp\/v2\/tags?post=858573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}